Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Sell
35
DERM Quote, Financials, Valuation and Earnings
Last price:
$6.05
Seasonality move
:
21.14%
Day range:
$5.96 - $6.35
52-week range:
$3.20 - $7.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.19x
P/B ratio:
6.94x
Volume:
82.9K
Avg. volume:
87K
1-year change:
39.91%
Market cap:
$139.3M
Revenue:
$56.1M
EPS (TTM):
-$0.74
Earnings Data
Next earnings date for DERM
May 13
2025
Most recent earnings per share
$0.08
Beat by $0.08
(Mar 26/2025)
Consensus Estimate
--
(Mar 26/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DERM Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $15.7M | -- | -- | -- | -- |
| 05/13/2025 | Q1 | $12.1M | -- | -- | -- | -- |
| 03/26/2025 | Q4 | $14.2M | $13.6M | $0.08 | -- | -- |
| 11/12/2024 | Q3 | $14.4M | $14.6M | -$0.12 | -- | -- |
| 08/12/2024 | Q2 | $13.9M | $14.9M | -$0.17 | -- | -- |
| 05/13/2024 | Q1 | $14.1M | $13M | -$0.53 | -- | -- |
| 03/21/2024 | Q4 | $15M | $15.3M | -$0.12 | -- | -- |
| 11/07/2023 | Q3 | $16.9M | $34.5M | $0.80 | -- | -- |
| 06/30/2023 | Q2 | $14.8M | $17.2M | -$0.46 | -- | -- |
| 03/31/2023 | Q1 | $16.2M | $12.2M | -$0.57 | -- | -- |
| 12/31/2022 | Q4 | $16.6M | $16M | -$0.60 | -- | -- |
| 09/30/2022 | Q3 | $17.7M | $16.1M | -$0.57 | -- | -- |
| 06/30/2022 | Q2 | -- | $18.3M | -$0.43 | -- | -- |
| 03/31/2022 | Q1 | -- | $23.3M | -$0.08 | -- | -- |
| 12/31/2021 | Q4 | -- | $17.5M | -$1.64 | -- | -- |
| 09/30/2021 | Q3 | -- | $19.6M | -$1.16 | -- | -- |
| 06/30/2021 | Q2 | -- | $15.3M | -$1.30 | -- | -- |
| 03/31/2021 | Q1 | -- | $10.7M | $0.03 | -- | -- |
| 12/31/2020 | Q4 | -- | $13.7M | $0.27 | -- | -- |
| 09/30/2020 | Q3 | -- | $9.4M | $0.00 | -- | -- |
| 06/30/2020 | Q2 | -- | $9.4M | $0.03 | -- | -- |
Journey Medical Earnings Questions
-
How Much did Journey Medical Generate in Revenue Last Quarter?
Journey Medical reported $13.6M worth of top line sales in its most recent quarter.
-
Did Journey Medical Beat Earnings Last Quarter?
Journey Medical announced earnings per share of $0.08 which represents a beat of analyst forecast a -- per share.
-
Is Journey Medical Profitable?
Journey Medical reported $11.4M that represents $0.53 per share over the last quarter.
-
What is the Analyst Consensus for Journey Medical EPS Next Year?
Journey Medical's earnings are forecast to grow from -$0.72 per share to -- per share next year representing an increase of --.
-
When is Journey Medical's Earnings Date?
Journey Medical's next earnings date is May 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
